Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER).

Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council. Arterioscler Thromb Vasc Biol (2015) 0.83

Effect and Safety of Rosuvastatin in Acute Ischemic Stroke. J Stroke (2016) 0.80

Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.80

Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis. Lipids Health Dis (2015) 0.77

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control. Circulation (2016) 0.76

Accuracy of low-density lipoprotein cholesterol estimation at very low levels. BMC Med (2017) 0.75

Very low LDL-C levels may safely provide additional clinical cardiovascular benefit: the evidence to date. Int J Clin Pract (2016) 0.75

Cancer risk in older people receiving statin therapy: a meta-analysis of randomized controlled trials. J Geriatr Cardiol (2016) 0.75

Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians. Ophthalmology (2013) 0.91

Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study). Am J Cardiol (2015) 0.80